A Long-term Trial of EB-1020 in Pediatric Patients With ADHD

Clinical trial NCT07087327 · RECRUITING

Trial details

NCT number: NCT07087327
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Attention-Deficit Hyperactivity Disorder(ADHD)

Start date: 2025-09-16
Primary completion: 2027-08-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.